Cargando…
Targeting Tumor Endothelial Cells with Nanoparticles
Because angiogenesis is a major contributor to cancer progression and metastasis, it is an attractive target for cancer therapy. Although a diverse number of small compounds for anti-angiogenic therapy have been developed, severe adverse effects commonly occur, since small compounds can affect not o...
Autores principales: | Sakurai, Yu, Akita, Hidetaka, Harashima, Hideyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928777/ https://www.ncbi.nlm.nih.gov/pubmed/31756900 http://dx.doi.org/10.3390/ijms20235819 |
Ejemplares similares
-
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
por: Hada, Tomoya, et al.
Publicado: (2015) -
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant
por: Miura, Naoya, et al.
Publicado: (2015) -
Effect of the Compaction and the Size of DNA on the Nuclear Transfer Efficiency after Microinjection in Synchronized Cells
por: Akita, Hidetaka, et al.
Publicado: (2015) -
Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain
por: Tamaru, Mina, et al.
Publicado: (2014) -
Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex
por: Hama, Susumu, et al.
Publicado: (2007)